CompletedPHASE1, PHASE2NCT04117711
Safety and Pharmacokinetics of AT-007 in Healthy Subjects and in Adult Subjects With Classic Galactosemia
Studying Galactosemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Applied Therapeutics, Inc.
- Principal Investigator
- Robert Green, MD, MPHBrigham and Women's Hospital
- Intervention
- AT-007(drug)
- Enrollment
- 114 enrolled
- Eligibility
- 18-55 years · All sexes
- Timeline
- 2019 – 2021
Study locations (4)
- Anaheim Clinical Trials, LLC, Anaheim, California, United States
- Atlanta Center for Medical Research, Atlanta, Georgia, United States
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- ICON Clinical Research, San Antonio, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04117711 on ClinicalTrials.govOther trials for Galactosemia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07461519Gonadic Function and Pubertal Development in Female Patients With Classic GalactosemiaIRCCS Azienda Ospedaliero-Universitaria di Bologna
- RECRUITINGNCT04948658Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated GonadectomyEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)